# Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D

> **NCT01442272** · PHASE4 · UNKNOWN · sponsor: **Hospital Universitario de Canarias** · enrollment: 174 (estimated)

## Conditions studied

- Kidney Failure, Chronic
- Disorder of Vitamin D

## Interventions

- **DRUG:** Hidroferol®
- **DRUG:** Paricalcitol: Zemplar®
- **DRUG:** Habitual medication

## Key facts

- **NCT ID:** NCT01442272
- **Lead sponsor:** Hospital Universitario de Canarias
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2012-10
- **Final completion:** 2013-10
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2012-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01442272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01442272, "Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01442272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*